Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
20,384,455
-
Share change
-
+214,708
-
Total reported value
-
$137,182,286
-
Price per share
-
$6.73
-
Number of holders
-
40
-
Value change
-
+$1,373,732
-
Number of buys
-
19
-
Number of sells
-
21
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q2 2020
As of 30 Jun 2020,
AC Immune SA - SHS (ACIU) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,384,455 shares.
The largest 10 holders included
BVF INC/IL, Temasek Holdings (Private) Ltd, Prosight Management, LP, Artal Group S.A., RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and WELLS FARGO & COMPANY/MN.
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.